title: Acute tumor lysis syndrome triggered by zoledronic Acid in a patient with metastatic lung adenocarcinoma.
abstract: We report the case of a 52-yr-old man with metastatic lung adenocarcinoma who developed tumor lysis syndrome after administration of zoledronic acid. Tumor lysis syndrome in solid tumors and the antitumor effect of the zolendronic acid are discussed in light of the pertinent literature.
authors.affiliation: Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
authors.forename: Mevlut
authors.initials: M
authors.lastname: Kurt
authors.forename: Ibrahim K
authors.initials: IK
authors.lastname: Onal
authors.forename: Tamer
authors.initials: T
authors.lastname: Elkiran
authors.forename: Bulent
authors.initials: B
authors.lastname: Altun
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Gullu
mesh_terms: D000208:Acute Disease; D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary*; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008175:Lung Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D015275:Tumor Lysis Syndrome / Q000097:blood / Q000175:diagnosis / Q000209:etiology*; D000077211:Zoledronic Acid
chemical_list: D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid